Prescription drug · ANDA
Piperacillin and Tazobactam NDC 0781-3110
Piperacillin sodium 2 g/10mL; Tazobactam sodium .25 g/10mL · Injection, Powder, Lyophilized, For solution · Intravenous, Parenteral · Sandoz Inc
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0781-3110-95 | 0078131109500781311095 | 10 VIAL, SINGLE-USE in 1 CARTON (0781-3110-95) / 10 mL in 1 VIAL, SINGLE-USE (0781-3110-90)Marketed from Oct 21, 2010 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Piperacillin and Tazobactam
- Generic name (nonproprietary)
- piperacillin and tazobactam
- Active ingredients
- Piperacillin sodium — 2 g/10mLTazobactam sodium — .25 g/10mL
- Dosage form
- Injection, Powder, Lyophilized, For solution
- Route
- Intravenous, Parenteral
- Labeler
- Sandoz IncNDC labeler code 0781
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 065362
- Marketing start
- Listing expires
- Other FDA classes
- Penicillins (Chemical structure)beta Lactamase Inhibitors (Mechanism)
- Identifiers
- Product ID 0781-3110_5432f00b-f1d7-4ac2-a9ea-ef6f1e7ef958SPL ID 5432f00b-f1d7-4ac2-a9ea-ef6f1e7ef958SPL set ID 9b682c66-61c6-4ade-baf4-9d68911a16b8RxCUI 1659131, 1659137, 1659149UNII M98T69Q7HP, UXA545ABTT
- Pharmacologic class
- Penicillin-class Antibacterial; beta Lactamase Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N400781311095followed by a unit qualifier and the quantityPackage 00781-3110-95. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Piperacillin and tazobactam for injection is a combination of piperacillin, a penicillin-class antibacterial and tazobactam, a beta-lactamase inhibitor, indicated for the treatment of: • Intra-abdominal infections in adult and pediatric patients 2 months of age and older ( 1.1 ) • Nosocomial pneumonia in adult and pediatric patients 2 months of age and older ( 1.2 ) • Skin and skin structure infections in adults ( 1.3 ) • Female pelvic infections in adults ( 1.4 ) • Community-acquired pneumonia in adults ( 1.5 ) To reduce the development of drug-resistant bacteria and maintain the effectiveness of piperacillin and tazobactam for injection and other antibacterial drugs, piperacillin and tazob…
Excerpt only. Read the full label for complete information.
About NDC 0781-3110
- What is NDC 0781-3110?
- 0781-3110 is the product NDC for Piperacillin and Tazobactam, Piperacillin sodium 2 g/10mL; Tazobactam sodium .25 g/10mL injection, powder, lyophilized, for solution, listed with the FDA by Sandoz Inc. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Piperacillin and Tazobactam.
- What is the active ingredient?
- Piperacillin sodium, Tazobactam sodium.
- Who is the labeler?
- Sandoz Inc, NDC labeler code 0781. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Piperacillin and Tazobactam?
- 59 other product NDCs are listed under this name. See all Piperacillin and Tazobactam NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Piperacillin and Tazobactam products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| piperacillin and tazobactam | Piperacillin sodium 3 g/15mL; Tazobactam sodium .375 g/15mL | Injection, Powder, For solutionIntravenous | Civica, Inc. | 72572-414 | 72572-0414-10 |
| piperacillin and tazobactam | Piperacillin sodium 4 g/20mL; Tazobactam sodium .5 g/20mL | Injection, Powder, For solutionIntravenous | Civica, Inc. | 72572-418 | 72572-0418-10 |
| Piperacillin and Tazobactam | Piperacillin sodium 36 g/180mL; Tazobactam sodium 4.5 g/180mL | Injection, Powder, For solutionIntravenous | Avenacy, LLC | 83634-112 | 83634-0112-99 |
| Piperacillin and Tazobactam | Piperacillin sodium 2 g/10mL; Tazobactam sodium .25 g/10mL | Injection, Powder, For solutionIntravenous | Avenacy, LLC | 83634-104 | 83634-0104-20 |
| Piperacillin and Tazobactam | Piperacillin sodium 3 g/15mL; Tazobactam sodium .375 g/15mL | Injection, Powder, For solutionIntravenous | Avenacy, LLC | 83634-105 | 83634-0105-30 |
| Piperacillin and Tazobactam | Piperacillin sodium 4 g/20mL; Tazobactam sodium .5 g/20mL | Injection, Powder, For solutionIntravenous | Avenacy, LLC | 83634-106 | 83634-0106-50 |
| Piperacillin and Tazobactampiperacillin sodium and tazobactam sodium | Piperacillin sodium 36 g/250mL; Tazobactam sodium 4.5 g/250mL | Injection, Powder, Lyophilized, For solutionIntravenous | Eugia US LLC | 55150-473 | 55150-0473-01 |
| Piperacillin and Tazobactampiperacillin sodium and tazobactam sodium | Piperacillin sodium 12 g/100mL; Tazobactam sodium 1.5 g/100mL | Injection, Powder, Lyophilized, For solutionIntravenous | Eugia US LLC | 55150-474 | 55150-0474-01 |
| Piperacillin and Tazobactam | Tazobactam sodium 4.5 g/180mL; Piperacillin sodium 36 g/180mL | Injection, Powder, Lyophilized, For solutionIntravenous | Apotex Corp. | 60505-6262 | 60505-6262-00 |
| Piperacillin and Tazobactam | Tazobactam sodium 4.5 g/180mL; Piperacillin sodium 36 g/180mL | Injection, Powder, Lyophilized, For solutionIntravenous | Shandong Anxin Pharmaceutical Co., Ltd. | 35369-0504 | 35369-0504-01 |
Other NDCs under ANDA 065362
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Piperacillin and Tazobactam | Piperacillin sodium 2 g/10mL; Tazobactam sodium .25 g/10mL | Injection, Powder, Lyophilized, For solutionIntravenous, Parenteral | Hospira, Inc | 0409-3383 |
| Piperacillin and Tazobactam | Piperacillin sodium 3 g/15mL; Tazobactam sodium .375 g/15mL | Injection, Powder, Lyophilized, For solutionIntravenous, Parenteral | Hospira, Inc | 0409-3385 |
| Piperacillin and Tazobactam | Piperacillin sodium 4 g/20mL; Tazobactam sodium .5 g/20mL | Injection, Powder, Lyophilized, For solutionIntravenous, Parenteral | Hospira, Inc | 0409-3390 |
| Piperacillin and Tazobactam | Piperacillin sodium 3 g/15mL; Tazobactam sodium .375 g/15mL | Injection, Powder, Lyophilized, For solutionIntravenous, Parenteral | Sandoz Inc | 0781-3113 |
| Piperacillin and Tazobactam | Piperacillin sodium 4 g/20mL; Tazobactam sodium .5 g/20mL | Injection, Powder, Lyophilized, For solutionIntravenous, Parenteral | Sandoz Inc | 0781-3114 |